[{"address1": "1065 East Hillsdale Boulevard", "address2": "Suite 100", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "650 525 5535", "fax": "650 275 4254", "website": "https://www.ternspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.", "fullTimeEmployees": 59, "companyOfficers": [{"maxAge": 1, "name": "Ms. Melita Sun Jung", "age": 47, "title": "Chief Business Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 508886, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew W. Gengos", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeffrey R. Jasper Ph.D.", "title": "Senior Vice President of Research", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Emil T. Kuriakose M.D.", "age": 44, "title": "Chief Medical Officer", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Harris", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Debra  Sieminski", "title": "Senior Vice President of Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James  Kanter", "title": "Senior VP of CMC", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yasameen  Qazen", "title": "Senior VP of Regulatory Affairs & Quality Assurance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David Eric Strauss", "age": 38, "title": "VP of Finance & Controller", "yearBorn": 1986, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 5, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.93, "open": 3.825, "dayLow": 3.71, "dayHigh": 3.925, "regularMarketPreviousClose": 3.93, "regularMarketOpen": 3.825, "regularMarketDayLow": 3.71, "regularMarketDayHigh": 3.925, "payoutRatio": 0.0, "beta": -0.194, "forwardPE": -2.791367, "volume": 998201, "regularMarketVolume": 998201, "averageVolume": 1012911, "averageVolume10days": 1000990, "averageDailyVolume10Day": 1000990, "bid": 3.86, "ask": 3.94, "bidSize": 9, "askSize": 9, "marketCap": 338870688, "fiftyTwoWeekLow": 1.865, "fiftyTwoWeekHigh": 11.4, "fiftyDayAverage": 2.9933, "twoHundredDayAverage": 5.234975, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 10208558, "profitMargins": 0.0, "floatShares": 58953016, "sharesOutstanding": 87337800, "sharesShort": 5438997, "sharesShortPriorMonth": 5415052, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.0623, "heldPercentInsiders": 0.0025099998, "heldPercentInstitutions": 1.00055, "shortRatio": 7.02, "shortPercentOfFloat": 0.0623, "impliedSharesOutstanding": 87337800, "bookValue": 3.735, "priceToBook": 1.038822, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -90388000, "trailingEps": -1.08, "forwardEps": -1.39, "enterpriseToEbitda": -0.099, "52WeekChange": -0.5125628, "SandP52WeekChange": 0.09203708, "quoteType": "EQUITY", "currentPrice": 3.88, "targetHighPrice": 34.0, "targetLowPrice": 14.0, "targetMeanPrice": 19.14286, "targetMedianPrice": 17.0, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 334264000, "totalCashPerShare": 3.827, "ebitda": -103560000, "totalDebt": 1235000, "quickRatio": 30.568, "currentRatio": 30.887, "debtToEquity": 0.379, "returnOnAssets": -0.2215, "returnOnEquity": -0.32123002, "freeCashflow": -44953500, "operatingCashflow": -71658000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TERN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Terns Pharmaceuticals, Inc.", "longName": "Terns Pharmaceuticals, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "postMarketChangePercent": 0.773195, "postMarketPrice": 3.91, "postMarketChange": 0.03, "regularMarketChange": -0.05, "regularMarketDayRange": "3.71 - 3.925", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1012911, "fiftyTwoWeekLowChange": 2.015, "fiftyTwoWeekLowChangePercent": 1.080429, "fiftyTwoWeekRange": "1.865 - 11.4", "fiftyTwoWeekHighChange": -7.5199995, "fiftyTwoWeekHighChangePercent": -0.6596491, "fiftyTwoWeekChangePercent": -51.256283, "earningsTimestamp": 1746734608, "earningsTimestampStart": 1754305140, "earningsTimestampEnd": 1754654400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.08, "epsForward": -1.39, "epsCurrentYear": -1.19178, "priceEpsCurrentYear": -3.2556345, "fiftyDayAverageChange": 0.88670015, "fiftyDayAverageChangePercent": 0.2962283, "twoHundredDayAverageChange": -1.3549747, "twoHundredDayAverageChangePercent": -0.25883117, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-05", "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "marketState": "CLOSED", "exchange": "NMS", "messageBoardId": "finmb_558294166", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.27226, "regularMarketPrice": 3.88, "corporateActions": [], "postMarketTime": 1749854065, "regularMarketTime": 1749844800, "displayName": "Terns Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-06-14"}]